Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double‐blind, placebo‐controlled trial

BACKGROUND: Immunotherapy with peptide hydrolysates from Lolium perenne (LPP) is an alternative treatment for seasonal allergic rhinitis with or without asthma. The aim of this study was to assess the clinical efficacy and safety of a cumulative dose of 170 μg LPP administered subcutaneously over 3 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Mösges, R., Bachert, C., Panzner, P., Calderon, M. A., Haazen, L., Pirotton, S., Wathelet, N., Durham, S. R., Bonny, M.‐A., Legon, T., von Frenckell, R., Pfaar, O., Shamji, M. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175232/
https://www.ncbi.nlm.nih.gov/pubmed/29512827
http://dx.doi.org/10.1111/all.13433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175232/
https://www.ncbi.nlm.nih.gov/pubmed/29512827
http://dx.doi.org/10.1111/all.13433

Ejemplares similares